{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T10:13:51Z","timestamp":1771928031862,"version":"3.50.1"},"reference-count":10,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>The syndrome of inappropriate antidiuresis (SIAD) has been associated with various diseases. However, to our knowledge, only a few studies have reported multiple myeloma (MM) as a potential cause of SIAD. We report a case where hyponatremia served as the primary clinical manifestation, diagnosed with SIAD and subsequently confirmed as multiple myeloma. Following anti-myeloma therapy, the hyponatremia was successfully corrected upon achieving a hematologic response classified as Very Good Partial Response (VGPR). This case contributes to an uncommon etiology of SIAD, highlighting the potential association between SIAD and multiple myeloma, and underscores the need for further research into this connection.<\/jats:p>","DOI":"10.3389\/fonc.2026.1697444","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T05:22:59Z","timestamp":1769664179000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Syndrome of inappropriate antidiuresis secondary to multiple myeloma: a case report and literature review"],"prefix":"10.3389","volume":"16","author":[{"given":"Linling","family":"Fan","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University","place":["Shanghai, China"]},{"name":"Department of Endocrinology and Metabolism, Yiyang Central Hospital","place":["Hunan, Yiyang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liya","family":"Mao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Huashan Hospital, Fudan University","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongying","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiming","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijin","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp2210411","article-title":"The syndrome of inappropriate antidiuresis","volume":"389","author":"Adrogue","year":"2023","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/00007611-198302000-00038","article-title":"Multiple myeloma and syndrome of inappropriate secretion of antidiuretic hormone","volume":"76","author":"Nanji","year":"1983","journal-title":"South Med J"},{"key":"B3","article-title":"Syndrome of inappropriate antidiuretic hormone due to multiple myeloma","volume":"108","author":"Abraham","year":"2011","journal-title":"Mo Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000000837","article-title":"A report on the syndrome of inappropriate anti-diuretic hormone secretion associated with multiple myeloma","volume":"133","author":"Tang","year":"2020","journal-title":"Chin Med J (Engl)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International myeloma working group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12124076","article-title":"Pseudohyponatremia: mechanism, diagnosis, clinical associations and management","volume":"12","author":"Aziz","year":"2023","journal-title":"J Clin Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-019-0128-y","article-title":"Bortezomib-induced hyponatremia: tolvaptan therapy permits continuation of lenalidomide, bortezomib and dexamethasone therapy in relapsed myeloma","volume":"8","author":"O\u2019Connor-Byrne","year":"2019","journal-title":"Exp Hematol Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-128-2-199801150-00009","article-title":"The pathophysiologic roles of interleukin-6 in human disease","volume":"128","author":"Papanicolaou","year":"1998","journal-title":"Ann Intern Med"},{"key":"B9","article-title":"Role of interleukin-6 in the pathogenesis of murine plasmacytoma and human multiple myeloma","volume":"151","author":"Pattengale","year":"1997","journal-title":"Am J Pathol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.4.863.bloodjournal854863","article-title":"Interleukin-6 in human multiple myeloma","volume":"85","author":"Klein","year":"1995","journal-title":"Blood"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1697444\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:23:56Z","timestamp":1771925036000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1697444\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":10,"alternative-id":["10.3389\/fonc.2026.1697444"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1697444","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"article-number":"1697444"}}